{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:01:18Z","timestamp":1773280878633,"version":"3.50.1"},"reference-count":13,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1971,2,1]]},"DOI":"10.1136\/jnnp.34.1.11","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:02:42Z","timestamp":1226350962000},"page":"11-13","source":"Crossref","is-referenced-by-count":8,"title":["Treatment of ocular myasthenia with corticotrophin"],"prefix":"10.1136","volume":"34","author":[{"given":"F. B.","family":"Gibberd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Navab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jnnp.32.4.290","article-title":"Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment","volume":"32","author":"Cape, C.A.; Utterback, R.A.","year":"1969","unstructured":"Cape, C. A., and Utterback, R. A. (1969). Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment. J. Neurol. Neurosrug. Psychiat., 32, 290-296.","journal-title":"J. Neurol. Neurosrug. Psychiat"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-52-4-806","article-title":"The place of corticotropin in the treatment of myasthenia gravis","volume":"52","author":"Freydberg, L.D.","year":"1960","unstructured":"Freydberg, L. D. (1960). The place of corticotropin in the treatment of myasthenia gravis. Ann. intern. Med., 52, 806-818.","journal-title":"Ann. intern. Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1966.03110200059018","article-title":"Corticotrophin in generalized myasthenia gravis. Effect of short, intensive courses","volume":"198","author":"Grob, D.; Namba, T.","year":"1966","unstructured":"Grob, D., and Namba, T. (1966). Corticotrophin in generalized myasthenia gravis. Effect of short, intensive courses. J. Amer. med. Ass., 198, 703-707.","journal-title":"J. Amer. med. Ass"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1212\/WNL.1.3.145","article-title":"Clinical evaluation of ACTH and cortisone in myasthenia gravis","volume":"1","author":"Millikan, C.H.; Eaton, L.M.","year":"1951","unstructured":"Millikan, C. H., and Eaton, L. M. (1951). Clinical evaluation of ACTH and cortisone in myasthenia gravis. Neurology (Minneap.), 1, 145-152.","journal-title":"Neurology (Minneap.)"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1964.03070010061013","article-title":"ACTH for ocular myasthenia","volume":"189","author":"Mount, F.W.","year":"1964","unstructured":"Mount, F. W. (1964a). ACTH for ocular myasthenia. J. Amer. med. Ass., 189, 55.","journal-title":"J. Amer. med. Ass"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archneur.1964.00460200010002","article-title":"Corticotropin in treatment of ocular myasthenia; a controlled clinical trial","volume":"11","author":"Mount, F.W.","year":"1964","unstructured":"Mount, F. W. (1964b). Corticotropin in treatment of ocular myasthenia; a controlled clinical trial. Arch. Neurol. (Chic.), 11, 114-124.","journal-title":"Arch. Neurol. (Chic.)"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.1966.03110200055017","article-title":"Studies in myasthenia gravis. Short-term massive corticotrophin therapy","volume":"198","author":"Osserman, K.E.; Genkins, G.","year":"1966","unstructured":"Osserman, K. E., and Genkins, G. (1966). Studies in myasthenia gravis. Short-term massive corticotrophin therapy. J. Amer. med. Ass., 198, 699-702.","journal-title":"J. Amer. med. Ass"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-60-1-130","article-title":"Myasthenia gravis and auto-immune disease. Review of the literature including a case report of the coexistence of myasthenia and systemic lupus erythematosus","volume":"60","author":"Piemme, T.E.","year":"1964","unstructured":"Piemme, T. E. (1964). Myasthenia gravis and auto-immune disease. Review of the literature including a case report of the coexistence of myasthenia and systemic lupus erythematosus. Ann. intern. Med., 60, 130-135.","journal-title":"Ann. intern. Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1749-6632.1966.tb45487.x","article-title":"Treatment of severe myasthenia gravis with large doses of ACTH","volume":"135","author":"von Reis, G.; Liljestrand, A.; Matell, G.","year":"1966","unstructured":"von Reis, G., Liljestrand, A., and Matell, G. (1966). Treatment of severe myasthenia gravis with large doses of ACTH. Ann. N. Y. Acad. Sci., 135, 409-416.","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: a new hypothesis","volume":"5","author":"Simpson, J.A.","year":"1960","unstructured":"Simpson, J. A. (1960). Myasthenia gravis: a new hypothesis. Scot. med. J., 5, 419-436.","journal-title":"Scot. med. J"},{"key":"ref_11","first-page":"12281235","article-title":"Effect of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis","volume":"28","author":"Torda, C.; Wolff, H.G.","year":"1949","unstructured":"Torda, C., and Wolff, H. G. (1949). Effect of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis. J. clin. Invest., 28, 12281235.","journal-title":"J. clin. Invest"},{"key":"ref_12","first-page":"\"163","article-title":"Effects of administration of adreno-corticotropic hormone (ACTH) in patients with myasthenia gravis","volume":"66","author":"Torda, C.; Wolff, H.G.","year":"1951","unstructured":"Torda, C., and Wolff, H. G. (1951). Effects of administration of adreno-corticotropic hormone (ACTH) in patients with myasthenia gravis. Arch. Neurol. Psychiat. (Chicago), 66, 163-170. van der Geld, H., Feltkamp, T. E. W., and Oosterhuis, H. J. G. H. (1964). Reactivity of myasthenia gravis serum y-globulin with skeletal muscle and thymus demonstrated by immunofluorescence. Proc. Soc. exp. Biol. (N. Y.), 115, 782-785.","journal-title":"Arch. Neurol. Psychiat. (Chicago); Reactivity of myasthenia gravis serum y-globulin with skeletal muscle and thymus demonstrated by immunofluorescence"},{"key":"ref_13","first-page":"120123","article-title":"The autoimmune response in myasthenia gravis","volume":"2","author":"White, R.G.; Marshall, A.H.E.","year":"1962","unstructured":"White, R. G., and Marshall, A. H. E. (1962). The autoimmune response in myasthenia gravis. Lancet, 2, 120123.","journal-title":"Lancet"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.34.1.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:25:38Z","timestamp":1601087138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.34.1.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1971,2,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1971,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.34.1.11","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1971,2,1]]}}}